Patent · US Active

Influenza hemagglutinin and neuraminidase variants

US8591914B2 · kind B2 · utility

29Cited by
24References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 9, 2009
Grant dateNov 26, 2013
Priority date—
Expiry dateJul 9, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16262
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.